400
Participants
Start Date
February 1, 2024
Primary Completion Date
December 31, 2030
Study Completion Date
December 31, 2030
Rivaroxaban
"Those in the non-interrupted anticoagulation group, anticoagulation is continued regardless of atrial fibrillation recurrence.~Those in the pill-in-the POCKET anticoagulation group will receive direct oral anticoagulation only if they have atrial fibrillation recur over 6 hours."
RECRUITING
Seoul National University Hospital, Seoul
Samjin Pharmaceutical Co., Ltd.
INDUSTRY
Medtronic Korea Co., Ltd.
UNKNOWN
Seoul National University Hospital
OTHER